Original Source(s)
Related Content
A Glimpse into the Future of Analytical Instrument Design?
Michael John Fanous’s portable scanner uses AI to reconstruct images blurred by continuous high-speed acquisition
October 7, 2026
-
7 min
Aptamer Tests Face the Validation Challenge
Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility
October 6, 2026
-
3 min
FDA clears targeted cholangiocarcinoma therapy
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
-
2 min
